Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NASDAQ:ONVO)

2.73
Delayed Data
As of Apr 24
 +0.02 / +0.74%
Today’s Change
2.41
Today|||52-Week Range
4.99
-19.47%
Year-to-Date
Biotech Movers: Organovo, Endo, Omeros
Apr 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.71
Today’s open2.75
Day’s range2.68 - 2.77
Volume689,364
Average volume (3 months)1,393,523
Market cap$283.0M
Dividend yield--
Data as of 04/24/2017

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+7.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book4.03

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...+0.25+6.17%
EDGEEdge Therapeutics In...+0.63+6.98%
VYGRVoyager Therapeutics...-0.02-0.19%
CYADCelyad SA+0.81+2.82%
Data as of 04/24/2017

Financials

Next reporting dateJune 15, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Taylor J. Crouch
Chief Financial Officer
Craig S. Kussman
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs